Contraception
Volume 76, Issue 6 , Pages 486-495 , December 2007

Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation

References 

  1. Finer LB, Henshaw SK. Estimates of U.S. Abortion Incidence, 2001–2003. Alan Guttmacher Institute. http://www.guttmacher.org/pubs/2006/08/03/ab_incidence.pdf2006;[Accessed 5/17/07] [Evidence Grade: II-3]
  2. Strauss LT, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S, et al. Abortion surveillance — United States, 2003. Morb Mortal Wkly Rep Surveill Summ. 2006;55:1–32[Evidence Grade: II-3]
  3. Haskell W, Easterline T, Lichtenberg ES. Surgical abortion after the first trimester. In:  Paul M,  Lichtenberg ES,  Borgatta L,  Grimes DA,  Stubblefield PG editor. A clinician's guide to medical and surgical abortion. London: Churchill Livingstone; 1999;p. 123–138[Evidence Grade: III]
  4. Altman AM, Stubblefield PG, Schlam JF, Loberfeld R, Osathanondh R. Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service. J Reprod Med. 1985;30:601–606[Evidence Grade: II-3]
  5. Hern WM. Serial multiple laminaria and adjunctive urea in late outpatient dilatation and evacuation abortion. Obstet Gynecol. 1984;63:543–549[Evidence Grade: II-3]
  6. Jacot FR, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F, et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol. 1993;168:633–637[Evidence Grade: II-2]
  7. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983;62:185–190[Evidence Grade: II-3]
  8. WHO Task Force on Sequelae of Abortion . Gestation, birthweight, and spontaneous abortion in pregnancy after induced abortion. Lancet. 1979;1143–1145[Evidence Grade: II-3]
  9. Hogue CJ, Cates W, Tietze C. The effects of induced abortion on subsequent reproduction. Epidemiol Rev. 1982;4:66–94[Evidence Grade: II-2]
  10. Munsick RA, Fineberg NS. Cervical dilation from multiple laminaria tents used for abortion. Obstet Gynecol. 1996;87:726–729[Evidence Grade: II-2]
  11. Stubblefield PG. Current technology for abortion. Curr Probl Obstet Gynecol. 1978;2:3–44[Evidence Grade: III-2]
  12. Eaton CJ, Cohn F, Bollinger CC. Laminaria tent as a cervical dilator prior to aspiration-type therapeutic abortion. Obstet Gynecol. 1972;39:535–537[Evidence Grade: II-3]
  13. Newton BW. Laminaria tent: relic of the past or modern medical device?. Am J Obstet Gynecol. 1972;113:442–448[Evidence Grade: II-3]
  14. Krammer J, O'Brien WF. Mechanical methods of cervical ripening. Clin Obstet Gynecol. 1995;38:280–286[Evidence Grade: III]
  15. Ye BL, Yamamoto K, Tyson JE. Functional and biochemical aspects of laminaria use in first-trimester pregnancy termination. Am J Obstet Gynecol. 1982;142:36–39[Evidence Grade: I]
  16. Wheeler RG, Schneider K. Properties and safety of cervical dilators. Am J Obstet Gynecol. 1983;146:597–601[Evidence Grade: II-3]
  17. Manabe Y, Mori T, Yoshida Y. Decidual morphology and F prostaglandin in amniotic fluid in stretch-induced abortion. Obstet Gynecol. 1984;64:661–665[Evidence Grade: III]
  18. Darney PD. Preparation of the cervix: hydrophilic and prostaglandin dilators. Clin Obstet Gynecol. 1986;13:43–51[Evidence Grade: III]
  19. MedGyn Products Inc . Package labeling: laminaria. 2007;Lombard (Ill)
  20. Bryman I, Granberg S, Norstrom A. Reduced incidence of postoperative endometritis by the use of laminaria tents in connection with first trimester abortion. Acta Obstet Gynecol Scand. 1988;67:323–325[Evidence Grade: I]
  21. Jonasson A, Larsson B, Bygdeman S, Forsum U. The influence of cervical dilatation by laminaria tent and with Hegar dilators on the intrauterine microflora and the rate of postabortal pelvic inflammatory disease. Acta Obstet Gynecol Scand. 1989;68:405–410[Evidence Grade: I]
  22. Acharya PS, Gluckman SJ. Bacteremia following placement of intracervical laminaria tents. Clin Infect Dis. 1999;29:695–697[Evidence Grade: III]
  23. Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv. 2004;59:528–536[Evidence Grade: III]
  24. Brenner WE, Zuspan K. Synthetic laminaria for cervical dilatation prior to vacuum aspiration in midtrimester pregnancy. Am J Obstet Gynecol. 1982;143:475–477[Evidence Grade: II-3]
  25. Medtronic . Package labeling: lamicel osmotic cervical dilator. 2007;Mystic (Conn)
  26. Nicolaides KH, Welch CC, MacPherson MB, Johnson IR, Filshie GM. Lamicel: a new technique for cervical dilatation before first trimester abortion. Br J Obstet Gynaecol. 1983;90:475–479[Evidence Grade: I]
  27. Bokstrom H, Wiqvist N. Prostaglandin release from human cervical tissue in the first trimester of pregnancy after preoperative dilatation with hygroscopic tents. Prostaglandins. 1995;50:179–188[Evidence Grade: II-1]
  28. Norstrom A, Bryman I, Hansson HA. Cervical dilatation by Lamicel before first trimester abortion: a clinical and experimental study. Br J Obstet Gynaecol. 1988;95:372–376[Evidence Grade: II-1]
  29. Nicolaides KH, Welch CC, Koullapis EN, Filshie GM. Cervical dilatation by Lamicel — studies on the mechanism of action. Br J Obstet Gynaecol. 1983;90:1060–1064[Evidence Grade: II-3]
  30. Radestad A, Christensen NJ. Magnesium sulphate and cervical ripening (a biomechanical double-blind, randomized comparison between a synthetic polyvinyl sponge with and without magnesium sulphate). Contraception. 1989;39:253–263[Evidence Grade: I]
  31. Tan SL, Cheng H, Ho KK, Mitra R, Hii J, Yeo KC. Lamicel is more effective in preparing the cervix for midtrimester termination of pregnancy than Laminaria japonicum. Aust N Z J Obstet Gynaecol. 1988;28:49–52[Evidence Grade: I]
  32. Grimes DA, Ray IG, Middleton CJ. Lamicel versus laminaria for cervical dilation before early second-trimester abortion: a randomized clinical trial. Obstet Gynecol. 1987;69:887–890[Evidence Grade: I]
  33. Wells EC, Hulka JF. Cervical dilation: a comparison of Lamicel and Dilapan. Am J Obstet Gynecol. 1989;161:1124–1126[Evidence Grade: I]
  34. Gupta JK, Johnson N. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?. Contraception. 1992;46:489–497[Evidence Grade: II-1]
  35. Gel-Med International . Package labeling: Dilapan-STM hygroscopic cervical dilator. http://www.gelmed.cz/instructions.html[Accessed 8/22/07]
  36. Chvapil M, Droegemueller W, Meyer T, Macsalka R, Stoy V, Suciu T. New synthetic laminaria. Obstet Gynecol. 1982;60:729–733[Evidence Grade: II-1]
  37. Hern WM. Cervical treatment with Dilapan prior to second trimester dilation and evacuation abortion: a pilot study of 64 patients. Am J Gynecol Health. 1993;7:23–26[Evidence Grade: II-3]
  38. Hern WM. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1001 patients. Am J Obstet Gynecol. 1994;171:1324–1328[Evidence Grade: I]
  39. Borgatta L, Barad D. Prolonged retention of laminaria fragments: an unusual complication of laminaria usage. Obstet Gynecol. 1991;78:988–990[Evidence Grade: III]
  40. Schulz KF, Grimes DA, Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1983;1:1182–1185[Evidence Grade: II-2]
  41. Lauersen NH, Den T, Iliescu C, Wilson KH, Graves ZR. Cervical priming prior to dilatation and evacuation: a comparison of methods. Am J Obstet Gynecol. 1982;144:890–894[Evidence Grade: II-1]
  42. Nguyen MT, Hoffman DR. Anaphylaxis to laminaria. J Allergy Clin Immunol. 1995;95(1 Pt 1):138–139[Evidence Grade: III]
  43. Chanda M, Mackenzie P, Day JH. Hypersensitivity reactions following laminaria placement. Contraception. 2000;62:105–106[Evidence Grade: III]
  44. Kim SH, Chang YH, Kim WK, Kim YK, Cho SH, Kim YY, et al. Two cases of anaphylaxis after laminaria insertion. J Korean Med Sci. 2003;18:886–888[Evidence Grade: III]
  45. Evaldson GR, Fianu S, Jonasson A, Larsson B, Nord CE, Olund AR. Does the hygroscopic property of the laminaria tent imply a risk for ascending infection in legal abortions? A microbiological study. Acta Obstet Gynecol Scand. 1986;65:257–261[Evidence Grade: II-2]
  46. Sutkin G, Capelle SD, Schlievert PM, Creinin MD. Toxic shock syndrome after laminaria insertion. Obstet Gynecol. 2001;98:959–961[Evidence Grade: III]
  47. Jasnosz KM, Shakir AM, Perper JA. Fatal Clostridium perfringens and Escherichia coli sepsis following urea-instillation abortion. Am J Forensic Med Pathol. 1993;14:151–154[Evidence Grade: II-3]
  48. Schneider D, Halperin R, Langer R, Caspi E, Bukovsky I. Abortion at 18–22 weeks by laminaria dilation and evacuation. Obstet Gynecol. 1996;88:412–414[Evidence Grade: II-2]
  49. Kalish RB, Chasen ST, Rosenzweig LB, Rashbaum WK, Chervenak FA. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol. 2002;187:882–885[Evidence Grade: II-3]
  50. Jackson JE, Grobman WA, Haney E, Casele H. Mid-trimester dilation and evacuation with laminaria does not increase the risk for severe subsequent pregnancy complications. Int J Gynaecol Obstet. 2007;96:12–15[Evidence Grade: II-2]
  51. Preterm birth: causes, consequences, and prevention (report in brief). Washington (DC): Institution of Medicine of the National Academies; 2006;http://www.iom.edu/Object.File/Master/35/975/pretermbirth.pdf[Accessed 5/29/07] [Evidence Grade: II-3]
  52. Blumenthal PD. Prospective comparison of Dilapan and laminaria for pretreatment of the cervix in second-trimester induction abortion. Obstet Gynecol. 1988;72:243–246[Evidence Grade: II-1]
  53. Darney PD, Dorward K. Cervical dilation before first-trimester elective abortion: a controlled comparison of meteneprost, laminaria, and hypan. Obstet Gynecol. 1987;70:397–400[Evidence Grade: I]
  54. Todd CS, Soler M, Castleman L, Rogers MK, Blumenthal PD. Buccal misoprostol as cervical preparation for second trimester pregnancy termination. Contraception. 2002;65:415–418[Evidence Grade: II-2]
  55. Goldberg AB, Drey EA, Whitaker AK, Kang MS, Meckstroth KR, Darney PD. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol. 2005;106:234–241[Evidence Grade: I]
  56. Castleman LD, Oanh KT, Hyman AG, Thuy le T, Blumenthal PD. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception. 2006;74:272–276[Evidence Grade: II-3]
  57. Edelman AB, Buckmaster JG, Goetsch MF, Nichols MD, Jensen JT. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. Am J Obstet Gynecol. 2006;194:425–430[Evidence Grade: I]
  58. Patel A, Talmont E, Morfesis J, Pelta M, Gatter M, Momtaz MR, et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006;73:420–430[Evidence Grade: II-3]
  59. Patsner B. Same-day Dilapan insertion before second-trimester dilation and evacuation for a fetal anomaly or death. J Reprod Med. 1996;41:71–72[Evidence Grade: III]
  60. Darney PD, Horbach NS, Korn AP. In: Second-trimester elective abortion. Protocols for office gynecologic surgery. Cambridge (Mass): Blackwell Science; 1996;p. 194–219[Evidence Grade: III]
  61. Gel-Med International . Package labeling: Dilapan-STM hygroscopic cervical dilator. Czech Republic. http://www.gelmed.cz/downloads/Dilapan_instruction_EN.pdf[Accessed 8/22/07]
  62. Hern WM, Zen C, Ferguson KA, Hart V, Haseman MV. Outpatient abortion for fetal anomaly and fetal death from 15–34 menstrual weeks' gestation: techniques and clinical management. Obstet Gynecol. 1993;81:301–306[Evidence Grade: II-3]
  63. Hern WM. Laminaria, induced fetal demise and misoprostol in late abortion. Int J Gynaecol Obstet. 2001;75:279–286[Evidence Grade: II-3]
  64. Stubblefield PG, Altman AM, Goldstein SP. Randomized trial of one versus two days of laminaria treatment prior to late midtrimester abortion by uterine evacuation: a pilot study. Am J Obstet Gynecol. 1982;143:481–482[Evidence Grade: I]
  65. Bierer I, Steiner V. Termination of pregnancy in the second trimester with the aid of laminaria tents. Med Gynaecol Sociol. 1972;6:9–10[Evidence Grade: III]
  66. Hern WM, Oakes AG. Multiple laminaria treatment in early midtrimester outpatient suction abortion: a preliminary report. Adv Plan Parent. 1977;12:93–97[Evidence Grade: III]
  67. Darney PD, Horbach NS, Korn AP. In: Cervical dilation for intrauterine procedures. Protocols for office gynecologic surgery. Cambridge (Mass): Blackwell Science; 1996;p. 143–157[Evidence Grade: III]
  68. Schneider D, Golan A, Langer R, Caspi E, Bukovsky I. Outcome of continued pregnancies after first- and second-trimester cervical dilatation by laminaria tents. Obstet Gynecol. 1991;78:1121–1123[Evidence Grade: II-3]
  69. Van Le L, Darney PD. Successful pregnancy outcome after cervical dilation with multiple laminaria tents in preparation for second-trimester elective abortion: a report of two cases. Am J Obstet Gynecol. 1987;156:612–613[Evidence Grade: III]
  70. Pastuszak AL, Schuler L, Speck-Martins CE, Coelho KE, Cordello SM, Vargas F, et al. Use of misoprostol during pregnancy and Mobius' syndrome in infants. N Engl J Med. 1998;338:1881–1885[Evidence Grade: II-2]
  71. Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VF, Sugayama SM, et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet. 2000;95:302–306[Evidence Grade: II-2]
  72. Schneider D, Bukovsky I, Caspi E. Safety of midtrimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section. Am J Obstet Gynecol. 1994;171:554–557[Evidence Grade: II-2]
  73. Pridmore BR, Chambers DG. Uterine perforation during surgical abortion: a review of diagnosis, management and prevention. Aust N Z J Obstet Gynaecol. 1999;39:349–353[Evidence Grade: II-3]
  74. Wing DA, Gaffaney CA. Vaginal misoprostol administration for cervical ripening and labor induction. Clin Obstet Gynecol. 2006;49:627–641[Evidence Grade: III]
  75. Herabutya Y, Chanarachakul B, Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet. 2003;83:293–297[Evidence Grade: II-2]
  76. Daskalakis GJ, Mesogitis SA, Papantoniou NE, Moulopoulos GG, Papapanagiotou AA, Antsaklis AJ. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG. 2005;112:97–99[Evidence Grade: II-2]
  77. Dickinson JE. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol. 2005;105:352–356[Evidence Grade: II-2]
  78. Daponte A, Nzewenga G, Dimopoulos KD, Guidozzi F. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section. Contraception. 2006;74:324–327[Evidence Grade: II-3]
  79. Bhattacharjee N, Ganguly RP, Saha SP. Misoprostol for termination of mid-trimester post-caesarean pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:23–25[Evidence Grade: II-2]
  80. Mazouni C, Provensal M, Porcu G, Guidicelli B, Heckenroth H, Gamerre M, et al. Termination of pregnancy in patients with previous cesarean section. Contraception. 2006;73:244–248[Evidence Grade: II-2]
  81. Berghahn L, Christensen D, Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol. 2001;98:976–977[Evidence Grade: III]
  82. Halperin R, Zimmerman A, Langer R, Bukovsky I, Schneider D. Laminaria dilatation and evacuation for pregnancies with mid-trimester premature rupture of membranes: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2002;100:181–184[Evidence Grade: II-2]
  83. Thomas AG, Alvarez M, Friedman F, Brodman ML, Kim J, Lockwood C. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol. 1994;84:58–60[Evidence Grade: II-2]
  84. Halperin R, Vaknin Z, Langer R, Bukovsky I, Schneider D. Late midtrimester pregnancy termination in the presence of placenta previa. J Reprod Med. 2003;48:175–178[Evidence Grade: II-2]

PII: S0010-7824(07)00419-2

doi: 10.1016/j.contraception.2007.09.004

Contraception
Volume 76, Issue 6 , Pages 486-495 , December 2007

Article Tools